Economics of Health Technology Assessment

Martina Garau presented at the last ISPOR Italy Chapter – Rome conference on the topic of economic gains produced by health interventions.

OHE is pleased to be hosting not one, not two but three seminars over the coming weeks.

Brockis, E., Marsden, G., Cole, A., and Devlin, N.

Research Paper
May 2016

NICE’s decisions exert an influence on the allocation of fixed NHS budgets, but decisions for different types of health interventions (for example drugs and devices) are handled via different ‘programmes’ within NICE.

Work by Sarah Karlsberg Schaffer (OHE), Jon Sussex (RAND Europe), Dyfrig Hughes (Bangor University) and Nancy Devlin (OHE) has recently been published in BMC Health Services Research.

OHE publishes new Consulting Report on shaping the research agenda to estimate relevant cost-effectiveness thresholds for Health Technology Assessment decision making.

Karlsberg Schaffer, S., Cubi-Molla, P., Devlin, N. and Towse, A.

Consulting Report
April 2016

This report details the views of a selection of experts in the fields of health and welfare economics on the cost-effectiveness threshold used by the National Institute for Health and Care Excellence (NICE) to decide which new medicines to recommend for use in the NHS, and the direction of future research in this area.

Just published is a book on the economics of end of life care, featuring a chapter by OHE’s Koonal Shah.

Dr Amanda Adler, Chair of NICE Appraisal Committee B and Consultant Physician, will present an OHE Seminar on 19 April 2016.

Two newly published OHE Research Papers report the methods and findings of the ‘EQ-5D-5L value set for England’ study.

Health interventions can produce economic gains for patients and national economies. In practice, however, the health-wealth link is rarely considered.

Pages

Subscribe to RSS - Economics of Health Technology Assessment